Robert R.
- Country
- The Netherlands
- Department
- Dermatology
Research Overview
- Evaluation of SYX-5219 on Immune Response Modulation in Patients with Atopic Dermatitis
- A Randomized, Double‑Blind, Placebo‑Controlled Trial Assessing TRIV‑509 on Skin Barrier Function in Adults with Atopic Dermatitis
- A Phase I Study to Evaluate the Safety, Tolerability, and Efficacy of LAD106 in Healthy Volunteers
Data & Insights
Has run more than one trial at 6 of 23 partner sites.
Specializations
Dermatology and Inflammatory Skin Disease
Robert Rissmann’s clinical research in Translational Dermatology includes therapeutic work in atopic dermatitis, psoriasis, and chronic urticaria, with attention to skin inflammation, itch, and barrier-related disease activity.
- Atopic dermatitis
- Psoriasis
- Chronic spontaneous urticaria
- Chronic inducible urticaria
His trial involvement also extends to eczema-related therapeutic assessment and cutaneous immune-mediated conditions.
Neurology and Neurodegenerative Disorders
His research landscape includes multiple neurological indications, with a strong focus on Parkinson’s disease, multiple sclerosis, epilepsy, and inherited neuromuscular disorders such as facioscapulohumeral muscular dystrophy and spinal muscular atrophy.
- Parkinson’s disease
- Progressive multiple sclerosis
- Epilepsy
- Facioscapulohumeral muscular dystrophy
Additional interests include frontotemporal dementia, stroke, and disorders linked to altered GABAergic signaling and neuronal excitability.
Pain Medicine and Neuropathic Pain
A major therapeutic area is chronic pain, especially neuropathic pain associated with diabetic peripheral neuropathy, alongside broader studies in analgesia and sensory dysfunction.
- Chronic neuropathic pain
- Diabetic peripheral neuropathy
- Opioid-induced respiratory depression
- Opioid use disorder
His work also covers pain-related pharmacology in healthy volunteers and participants with persistent pain syndromes.
Autoimmune, Rheumatologic, and Lupus Conditions
Robert Rissmann is involved in clinical research across systemic immune-mediated diseases, including rheumatoid arthritis, systemic lupus erythematosus, and cutaneous lupus variants, reflecting a broad interest in autoimmunity and inflammatory disease.
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Discoid lupus erythematosus
- Subacute cutaneous lupus erythematosus
His portfolio also includes immune system diseases and broader inflammatory diseases with dermatologic and systemic overlap.
Neuropsychiatry, Respiratory, and Translational Pharmacology
His clinical trial activity spans major depressive disorder, generalized anxiety disorder, and related neuropsychiatric conditions, together with studies in opioid-induced respiratory depression and healthy-volunteer pharmacology.
- Major depressive disorder
- Generalized anxiety disorder
- Opioid-induced respiratory depression
- Healthy volunteer pharmacology
His research also touches on cortical excitability, remyelination, and other translational CNS endpoints relevant to medical innovation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.